Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/29/2001 | US20010046497 Contacting a mammalian SP168 (polypeptide) receptor or fragment in presence of known amount of labelled SP168 receptor ligand with a sample to be tested for the presence or absence of SP168 receptor agonist or antagonist |
11/29/2001 | US20010046490 Cell surface molecule-induced macrophage activation |
11/29/2001 | US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
11/29/2001 | US20010046461 Transmission meter, a method of measuring transmittance and a disinfection apparatus |
11/29/2001 | US20010046453 For performing diagnostic assay without use of external power source |
11/29/2001 | US20010046452 Immunological assay system and method |
11/29/2001 | US20010045517 Non-destructive sugar content measuring apparatus |
11/29/2001 | US20010045475 Chewing apparatus |
11/29/2001 | US20010045380 Spa chemistry monitor unit |
11/29/2001 | US20010045359 Separation of cell particle by dielectrophoresis |
11/29/2001 | US20010045355 Medical diagnostic system |
11/29/2001 | US20010045119 Method and apparatus for determining concentration of a gas |
11/29/2001 | DE10122173A1 Monitoring of dissolved gases in fluid filled high voltage units, e.g. transformer, comprises disturbing equilibrium between gaseous and liquid states, raising separating chamber pressure, and removing gas for analysis |
11/29/2001 | DE10122112A1 Device for measuring thermal stresses in concrete structures has metal plate connecting T-frames to form housing enclosing concrete, cellophane tape applied to inside of concrete structure |
11/29/2001 | DE10032040A1 Antikörper gegen spezielle Formen des proPSA und deren Verwendung in Immunoassays Antibodies against specific forms of proPSA and their use in immunoassays |
11/29/2001 | DE10027683A1 Rheometric affinity sensor determining large molecule analytes, promotes interaction with immobilized affinity-binding partner, causing measurable change in flow characteristics |
11/29/2001 | DE10027201A1 Laboratory apparatus for investigating hot-coating behavior of plastic powders, comprises detachable powder box held to swinging hot plate |
11/29/2001 | DE10026172A1 System zur Entnahme von Körperflüssigkeit System for withdrawing body fluid |
11/29/2001 | DE10024598A1 Vorrichtung und Verfahren zur automatischen Qualitätskontrolle von Prüflingen Apparatus and method for automated quality control of specimens |
11/29/2001 | DE10024500A1 Treatment of water or aqueous liquid or solution by tea-bag or infuser method, used to purify drinking water or sewage or prepare drink or pharmaceutical formulation, includes introducing and separating gas bubbles |
11/29/2001 | DE10024309A1 Verfahren und Vorrichtung zur trockenen Auftrennung von Sammelmüll mit Verpackungsabfällen Method and apparatus for dry separation of garbage collection with packaging waste |
11/29/2001 | DE10022501A1 Determination of grape must putrefaction as quality indicator, comprises introducing light into must for spectrometric evaluation |
11/29/2001 | CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
11/29/2001 | CA2704596A1 Method for examining wt1-related disease |
11/29/2001 | CA2447960A1 Scanning kelvin microprobe system and process for biomolecule microassay |
11/29/2001 | CA2447929A1 Scanning kelvin microprobe system and process for analyzing a surface |
11/29/2001 | CA2410642A1 Modulation of t-cell receptor interactions |
11/29/2001 | CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/29/2001 | CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
11/29/2001 | CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/29/2001 | CA2409868A1 Modulaton of alpha-6 integrin-mediated responses |
11/29/2001 | CA2409857A1 Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof |
11/29/2001 | CA2409774A1 Methods for genetic analysis of dna to detect sequence variances |
11/29/2001 | CA2409772A1 Antiviral therapy |
11/29/2001 | CA2409309A1 Materials and methods for detection of nucleic acids |
11/29/2001 | CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer |
11/29/2001 | CA2409298A1 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity |
11/29/2001 | CA2408883A1 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
11/29/2001 | CA2408749A1 Drug screening systems and assays |
11/29/2001 | CA2408743A1 Method of detecting inflammatory lung disorders |
11/29/2001 | CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses |
11/29/2001 | CA2408728A1 Compositions and methods for nucleic acid or polypeptide analyses |
11/29/2001 | CA2408574A1 Microfluidic concentration gradient loop |
11/29/2001 | CA2408566A1 Role of ldl receptor protein-1 (lrp-1) in alzheimer's disease |
11/29/2001 | CA2408315A1 Aminoacyl trna synthetases |
11/29/2001 | CA2408302A1 Long wavelength engineered fluorescent proteins |
11/29/2001 | CA2408141A1 Neurotransmitter transporters |
11/29/2001 | CA2408140A1 G-protein coupled receptors |
11/29/2001 | CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
11/29/2001 | CA2407872A1 Receptor-based interaction trap |
11/29/2001 | CA2407793A1 Differential spr sensor and measuring method using it |
11/29/2001 | CA2407545A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
11/29/2001 | CA2378854A1 Methods and computer software products for transcriptional annotation |
11/28/2001 | EP1158449A2 Computerized method and apparatus for analyzing readings of nucleic acid assays |
11/28/2001 | EP1158447A1 Method for evaluating states of biological systems |
11/28/2001 | EP1158299A1 Method for assaying biological sample component |
11/28/2001 | EP1158298A1 Method for presuming restenosis following coronary vessel intervention |
11/28/2001 | EP1158297A1 Method for screening compound having affinity for vitamin d receptor |
11/28/2001 | EP1158296A2 Machine for automated quality control of ceramic products by artificial vision and sound analysis |
11/28/2001 | EP1158288A1 Process for fast optimization of physical properties of solid materials consisting of metalic or chemical components, by determining the ideal composition of said components |
11/28/2001 | EP1158139A2 Pyrolytic oil-productivity index method for predicting reservoir rock and oil characteristics |
11/28/2001 | EP1158058A1 Compositions and methods suitable for nucleic acid analyses |
11/28/2001 | EP1158055A1 Method for diagnosing cancers |
11/28/2001 | EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2) |
11/28/2001 | EP1158048A1 Photoprotein derived from Okinawan squid and gene encoding the photoprotein |
11/28/2001 | EP1158044A1 Method for inducing differentiation into adipocytes, compound regulating differentiation into adipocytes and method for screening the same |
11/28/2001 | EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
11/28/2001 | EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms |
11/28/2001 | EP1158002A1 Human G-protein coupled receptor |
11/28/2001 | EP1157984A2 Trypsin substrate and diagnostic device, and method of using same |
11/28/2001 | EP1157743A1 Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
11/28/2001 | EP1157737A2 Methods and apparatus for producing biochips |
11/28/2001 | EP1157431A1 A hybrid electrical device with biological components |
11/28/2001 | EP1157276A1 Method for evaluating the intensity of muscular proteolysis |
11/28/2001 | EP1157275A1 Novel transduction molecules and methods for using same |
11/28/2001 | EP1157274A1 Methods of determining altered ndpk functions |
11/28/2001 | EP1157273A1 Method and apparatus for measuring hemostasis |
11/28/2001 | EP1157272A1 Oil quality sensor and method for producing the same |
11/28/2001 | EP1157270A1 Multichannel control in microfluidics |
11/28/2001 | EP1157266A1 Surface plasmon resonance sensor |
11/28/2001 | EP1157265A1 Method for measuring the concentration or the partial pressure of gases, especially oxygen, in fluids and a corresponding gas sensor |
11/28/2001 | EP1157133A1 Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system |
11/28/2001 | EP1157132A1 Aptamers as reagents for high throughput screening |
11/28/2001 | EP1157128A2 Homogeneous enzymatic assay for vitamin b6 |
11/28/2001 | EP1157127A1 Viability assay for sporocyst-forming protozoa |
11/28/2001 | EP1157126A1 Method for cloning signal transduction intermediates |
11/28/2001 | EP1157118A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
11/28/2001 | EP1157109A2 14273 receptor, a g-protein coupled receptor |
11/28/2001 | EP1157104A2 Pyk2 binding proteins |
11/28/2001 | EP1157092A1 Nano-grid micro reactor and methods |
11/28/2001 | EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
11/28/2001 | EP1157041A2 Antibodies for cancer therapy and diagnosis |
11/28/2001 | EP1157036A1 Immunomodulating glycopeptide |
11/28/2001 | EP1157035A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
11/28/2001 | EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
11/28/2001 | EP1157029A1 Oligopeptide derivatives for the electrochemical measurement of protease activity |
11/28/2001 | EP1156835A2 Kit for radiolabeling proteins with yttrium-90 |
11/28/2001 | EP1156833A1 Metastasis models using green fluorescent protein (gfp) as a marker |
11/28/2001 | EP1156826A1 Product and method for treatment of conditions associated with receptor-desensitization |
11/28/2001 | EP1156819A1 Methods and compositions for modulating fertility |